Uses of Vorier 200mg Tablet

Vorier 200mg Tablet is used for the treatment or prevention of the following disease(s):

Fungal Infections

Side effects of Vorier 200mg Tablet

Precautions while taking Vorier 200mg Tablet

Dosage of Vorier 200mg Tablet

Overdose of Vorier 200mg Tablet

Onset of Action of Vorier 200mg Tablet

Duration of Action of Vorier 200mg Tablet

Precautions & Warnings

Alcohol

Information will be added soon.

Pregnancy

Information will be added soon.

Breastfeeding

Information will be added soon.

Driving

Information will be added soon.

Kidney

Information will be added soon.

Liver

Information will be added soon.

All substitutes for Vorier 200mg Tablet

For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.

Interactions

Drug :- alfentanil: Increased plasma alfentanil level and increased risk of adverse reactions.

benzodiazepines: Possibly prolonged sedative effect of benzodiazepines.

calcium channel blockers, HMG-CoA reductase inhibitors, such as lovastatin, omeprazole, sirolimus: Possibly increased plasma levels of these drugs, leading to increased risk of adverse reactions and toxicity.

carbamazepine, long-acting barbiturates, phenytoin, rifampin: Decreased plasma voriconazole concentration.

coumarin, warfarin: Possibly increased PTT cyclosporine, sirolimus, tacrolimus: Increased serum concentrations of these drugs and risk of toxicity, especially nephrotoxicity.

CYP3A4 substrates astemizole, cisapride, pimozide, quinidine, terfenadine: Increased plasma levels of these drugs, which may lead to prolonged QT interval and, rarely, torsades de pointes.

ergot alkaloids ergotamine, dihydroergotamine: May increase plasma level of ergot alkaloids, leading to ergotism.

HIV protease inhibitors amprenavir, nelfinavir, ritonavir, saquinavir, non-nucleoside reverse transcriptase inhibitors delavirdine, efavirenz: Possibly inhibited metabolism of these drugs and voriconazole.

methadone: Increased plasma level of methadone, possibly leading to toxicity, including QT-interval prolongation.

oral contraceptives: Increased plasma voriconazole level and risk of toxicity.

rifabutin: Increased rifabutin plasma level, decreased voriconazole plasma level.

St. John's wort: Decreased plasma voriconazole level.

sulfonylureas: Possibly increased plasma level of sulfonylureas and increased risk of hypoglycemia.

vinca alkaloids: Possibly increased risk of neurotoxicity.

Kunal is a registered pharmacist with RGUHS with over 4 years experience. He is a medicine content contributor at Health-Shoppe.com.